An analysis of the relationship of leukemic cell kinetics to chemotherapy.
D001853:Bone Marrow / Q000254:growth & development* / Q000528:radiation effects; D001854:Bone Marrow Cells; D003561:Cytarabine / Q000627:therapeutic use; D004247:DNA / Q000096:biosynthesis; D003630:Daunorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006412:Hematopoietic Stem Cells / Q000254:growth & development; D006801:Humans; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy* / Q000532:radiotherapy; D008727:Methotrexate / Q000627:therapeutic use; D008938:Mitosis / Q000187:drug effects; D011241:Prednisone / Q000627:therapeutic use; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014750:Vincristine / Q000627:therapeutic use
D003561:Cytarabine; D014316:Tritium; D014750:Vincristine; D004247:DNA; D011241:Prednisone; D013936:Thymidine; D008727:Methotrexate; D003630:Daunorubicin